Pentagon quietly gains power to define which tech counts as national defense

What it does

This bill amends the Defense Production Act of 1950 to require the Defense Production Act Committee to meet at least twice per year, authorize the Committee chair to establish subcommittees, and create a mandatory Subcommittee on Emerging Technology. The new subcommittee will analyze how artificial intelligence, biotechnology, quantum computing, semiconductors, and other advanced technologies can support national defense and improve supply chains. Within 18 months, the subcommittee must report to Congress on whether the U.S. should establish a strategic reserve of critical biomanufacturing inputs.

Why we flagged it

The bill's operative mechanism is administrative restructuring of an existing interagency committee to improve coordination on emerging technologies relevant to national defense. It does not create new spending, regulate private conduct, or establish new rights—it reorganizes government decision-making.

• Section 4 corrects a typographical error in the Defense Production Act of 1950's short title (striking 'the Defense' and inserting 'the 'Defense'). Substantively unrelated to the bill's core purpose of establishing the Emerging Technology Subcommittee.

What the text implies

• The bill grants the Committee Chairperson unilateral authority to establish subcommittees without congressional approval, potentially expanding the scope of interagency coordination beyond what Congress explicitly authorized.
• The Subcommittee's mandate to 'establish a definition for covered technology' gives an unelected interagency body the power to define which technologies fall under national defense authority—a definitional power that could expand or contract the DPA's reach.
• The 18-month biomanufacturing reserve study may lay groundwork for a government-controlled strategic reserve of pharmaceutical/biotech inputs, which could affect private pharmaceutical supply chains and pricing if implemented.
• The bill does not specify which agencies sit on the Subcommittee or how decisions are made, leaving governance structure to internal DPA Committee rules rather than statute.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill creates a coordination mechanism for national defense supply chains and emerging technologies, which may improve resilience and innovation in critical sectors benefiting the public. However, the bill itself contains no direct public benefit, transparency requirement, or accountability mechanism—it is purely an internal government reorganization. The strategic biomanufacturing reserve, if adopted, could affect drug and vaccine supply chains, but the bill only mandates a study, not implem

Who stands to gain

• semiconductor manufacturers (if supply chain coordination reduces bottlenecks)
• biotechnology and biomanufacturing firms (if strategic reserve is adopted)
• defense contractors (if emerging technology coordination accelerates procurement)

Named in the bill

Defense Production Act Committee, Subcommittee on Emerging Technology, Defense Production Act of 1950, artificial intelligence, biotechnology, quantum computing, semiconductors, biomanufacturing

Where it stands

• Mar 24, 2026 — Introduced · Congress.gov: “Introduced in House”
• Mar 24, 2026 — Referred to House Committee on Financial Services · Congress.gov: “Referred to the House Committee on Financial Services”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.